3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Influenza, Human
15
Neoplasms
7
Leukemia, Lymphocytic, Chronic, B-Cell
5
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia
3
Colorectal Neoplasms
3
Neoplasms, Plasma Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Central Nervous System Neoplasms
2
Anemia, Aplastic
2
Waldenstrom Macroglobulinemia
1
Vaccine-Preventable Diseases
1
Vaccination Hesitancy
1
Skin Neoplasms
1
Sezary Syndrome
1
Serology Analysis
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Primary Myelofibrosis
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Patient Acceptance of Health Care
1
Pancreatic Neoplasms
1
Interventions
Surveys and Questionnaires
6
Standard of Care
6
Blood Specimen Collection
6
BNT162 Vaccine
5
Hydroxychloroquine
4
Surgical Procedures, Operative
3
Specimen Handling
3
Practice Guidelines as Topic
3
COVID-19 Vaccines
3
2019-nCoV Vaccine mRNA-1273
3
tocilizumab
2
sotrovimab
2
Pandemic Preparedness
2
CVnCoV COVID-19 vaccine
2
Azithromycin
2
sinovac COVID-19 vaccine
1
selinexor
1
remdesivir
1
ogalvibart
1
monalizumab
1
lenzilumab
1
heterologous prime boost COVID-19 vaccination
1
crexavibart
1
cilgavimab and tixagevimab drug combination
1
ciclesonide
1
avdoralimab
1
XAV-19
1
Therapeutics
1
Telemedicine
1
Sperm Count
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
COVID-19
×
Influenza Vaccines
×
Clear all
NCT06124131
2025-05-04
BENEFIT-C
Tulane University
Phase NA
Completed
50 enrolled
15 charts